Institutional Ownership
Neurocrine Biosciences Inc
CUSIP 64125C109COMNBIXQ1 2026
Institutional Holders
682
13F filers
Shares Held
89.51M
Aggregate institutional
Institutional Value
$11.46B
Q1 2026
Net New Holders
-36
70 new · 106 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions70
Increased297
Decreased216
Sold out106
Institutional Holders
682 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 13.39M | $1.76B | +555.0K | Added |
| 2 | Dodge & Cox | 5.46M | $719.44M | −47.0K | Reduced |
| 3 | Jpmorgan Chase & Co | 5.44M | $700.50M | +241.7K | Added |
| 4 | Aqr Capital Management LLC | 4.94M | $650.66M | +1.67M | Added |
| 5 | State Street Corp | 4.35M | $573.67M | +111.8K | Added |
| 6 | Two Sigma Investments, LP | 3.06M | $403.20M | +2.08M | Added |
| 7 | Renaissance Technologies LLC | 2.42M | $318.67M | +180.1K | Added |
| 8 | Geode Capital Management, LLC | 2.14M | $280.80M | +77.4K | Added |
| 9 | Bnp Paribas Asset Management Holding S.A. | 1.49M | $196.77M | +97.9K | Added |
| 10 | Wellington Management Group LLP | 1.39M | $183.06M | −355.0K | Reduced |
672 more institutional holders on Premium
See every fund holding Neurocrine Biosciences Inc, with full quarter-over-quarter share changes.
Unlock all holders